Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Correspondent™ provides on-site daily coverage of key sessions at particular scientific meetings. Conference Correspondent™ takes healthcare providers to meetings they cannot attend live, and your sponsorship helps create awareness for your brand or therapeutic area.
View All Conference Highlights
ASH 2023 - CLL
MRD-Guided Zanubrutinib, Venetoclax and Obinutuzumab Maintenance in Relapsed/Refractory CLL
ASH 2023 - CLL
– December 14, 2023
American Society of Hematology (ASH)
Response to Subsequent Novel Therapies and Time to Second Progression-Free Survival Event in the MURANO Trial in Patients with R/R CLL Previously Treated with Fixed-Dose Venetoclax/Rituximab
ASH 2023 - CLL
– December 14, 2023
American Society of Hematology (ASH)
VIEW FULL COVERAGE
SABCS 2023 HER2+ MBC
Phase 3 HER2CLIMB-02 Trial Results of Tucatinib Plus Trastuzumab Emtansine in Previously Treated HER2+ MBC
SABCS 2023 HER2+ MBC
– December 8, 2023
San Antonio Breast Cancer Symposium (SABCS)
Correlation of Circulating Tumor Cells with Clinicopathological Factors and Treatment Response in MBC
SABCS 2023 HER2+ MBC
– December 8, 2023
San Antonio Breast Cancer Symposium (SABCS)
VIEW FULL COVERAGE
SABCS 2023 HR+/HER2- MBC
CKD4/6 Inhibitors Found to Be Less Effective in Patients with HR+/HER2- Metastatic Breast Cancer with Bone-Only Metastases
SABCS 2023 HR+/HER2- MBC
– December 11, 2023
San Antonio Breast Cancer Symposium (SABCS)
Action Plans and Educational Resources Found to Increase Oral Medication Compliance in Patients with Breast Cancer
SABCS 2023 HR+/HER2- MBC
– December 11, 2023
San Antonio Breast Cancer Symposium (SABCS)
VIEW FULL COVERAGE
ESMO 2023 - Small Cell Lung Cancer
DLL3-Targeting T-Cell Engager HPN328 Shows Clinical Activity in SCLC and NEN
ESMO 2023 - Small Cell Lung Cancer
– October 26, 2023
European Society for Medical Oncology (ESMO)
Induction Therapy With PD-L1 Inhibitor TQB2450 + Chemotherapy Followed by Surgery or Radiotherapy in Limited-Stage SCLC
ESMO 2023 - Small Cell Lung Cancer
– October 26, 2023
European Society for Medical Oncology (ESMO)
VIEW FULL COVERAGE
ASCO 2023 - Breast Cancer
Anti-HER2/HER3 αDC1 Vaccines Plus Pembrolizumab for Brain Metastasis in Triple-Negative or HER2-Positive BC
ASCO 2023 - Breast Cancer
– June 7, 2023
American Society of Clinical Oncology (ASCO)
Neoadjuvant Intratumoral Dendritic Cell Vaccine Therapy Plus Paclitaxel, Trastuzumab, and Pertuzumab in HER2-Positive BC
ASCO 2023 - Breast Cancer
– June 7, 2023
American Society of Clinical Oncology (ASCO)
VIEW FULL COVERAGE
ONS 2023 - Multiple Myeloma: Wrap-Up
Emerging Treatment Landscape for Multiple Myeloma
ONS 2023 - Multiple Myeloma: Wrap-Up
– May 9, 2023
Oncology Nursing Society (ONS)
Nursing Considerations for Select Multiple Myeloma Treatments
ONS 2023 - Multiple Myeloma: Wrap-Up
– May 9, 2023
Oncology Nursing Society (ONS)
VIEW FULL COVERAGE
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us